Skip to content

DIAPHARMA

Active Private limited companyfounded 2001active for 25 yearsGemeentestraat 72, 3010 LeuvenKBO/BCE: BE 0474.698.006

Lifetime

19 annual accounts with figures on one time axis, 24 filings since 2002
peak of €193,157 in 2013
€105,503▲ 23.2%
lowest -€79,999 in 2021
€51,639▲ 13.8%
peak of €544,835 in 2019
€357,269▲ 16.9%
€243,074▼ 41.0%
peak of 0.6 FTE in 2007
-not published
Board1 name since 2001
1 director
Documentsfilings and deeds
06-08-20266 days late
2025micro format
Gross margin from €85,648 to €105,503Equity from €305,629 to €357,269Debts from €412,254 to €243,074Investments €7,608

Key points

from the 2025 annual accounts

Equity

€357,269 ▲ 16.9%

DIAPHARMA has made a profit without a break since 2022.

Turnover

≈ €370,000 estimated

The accounts state no turnover.

Investments

€7,608 1.9 times depreciation
202220232025

Green is investment, beige is depreciation. Machinery stands 24.2% higher than in 2024.

Liquidity

2.60 was 1.79 in 2024

Short-term debts fell from €392,183 to €224,064.

Filings

24 annual accounts since 2002
AprilJune31 JulyOctober20102020

Seven of the last ten came late. The 2019 accounts came in latest, 29 days after the end of the period.

Position in the sector

€357,269

More equity than 92% of companies in retail trade. Sector median €40,852 · 25,371 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,147 companies had the same profile as DIAPHARMA has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,912 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,147 companies, not a prediction for DIAPHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 26-04-2001
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0474698006
Capital conversion General meeting of 20-11-2023 · Gazette deed
Amendment of the articles · Legal-form change · Resignations & appointments General meeting of 20-11-2023 · Gazette deed
First establishment Gemeentestraat 72, Leuven
All 34 events

Comparable companies

same main activity, similar in size and age
Company
DIAPHARMA Leuven €600,343 €105,503 59.5% -
APOTHEEK WINTERS MAASEIK Maaseik €648,309 €111,001 23.7% 1.8
APOTHEEK MOEREMANS Ninove €590,537 €102,118 54.5% -
LAIVAPHAR Tienen €679,253 €101,142 55.8% -
FARMA DE HEIDE Londerzeel €529,320 €126,053 42.8% 1.4
T.LAMOTE Merchtem €663,074 €104,272 61.0% -
VAN DE WEYER APOTHEEK Landen €661,590 €123,286 88.6% 0.9

These companies have the same main activity as DIAPHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €529,000 and €679,000, founded between 1995 and 2006.

Official details

Source: KBO
Status
Active since 26-04-2001Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2022
Establishment unit
2.229.086.6253010 Leuven, since 01-06-2001
Financial year end
31 December
Peppol
Reachable since 27-11-2025
Company details

Annual accounts 2025

€600,343▼ 16.4%
Filing
Filed on 06-08-2026
Financials

Insights on DIAPHARMA

DIAPHARMA files the micro format. That format states no turnover. The gross margin fell from €165,536 in 2007 to €105,503 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DIAPHARMA

What is the company number of DIAPHARMA?
The company number of DIAPHARMA is 0474.698.006. The VAT number is the same number with BE in front: BE 0474.698.006.
Where is DIAPHARMA based?
The registered office is at Gemeentestraat 72, 3010 Leuven.Company details
What does DIAPHARMA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of DIAPHARMA?
DIAPHARMA is a private limited company (BV).
When was DIAPHARMA founded?
DIAPHARMA was founded on 26-04-2001.
Is DIAPHARMA still active?
Yes, DIAPHARMA is an active enterprise in the KBO register.
How many employees does DIAPHARMA have?
DIAPHARMA had an average of 0.5 full-time equivalents in financial year 2021, according to the filed annual accounts.Financials
Which joint committee does DIAPHARMA fall under?
In its 2022 annual accounts, DIAPHARMA states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of DIAPHARMA?
The turnover in financial year 2025 is ≈ €370,000. This figure is estimated from the gross margin of €105,503 and 38 comparable companies (NACE 477). It probably lies between €280,000 and €610,000.
Is DIAPHARMA profitable?
In financial year 2025, DIAPHARMA made a profit of €51,639.
Where can I find the annual accounts of DIAPHARMA?
DIAPHARMA filed 24 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DIAPHARMA due?
DIAPHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.